Drug Side Effects
Search
NEUROENDOCRINE CANCER OF THE PROSTATE METASTATIC
NEUROENDOCRINE CANCER OF THE PROSTATE METASTATIC
was reported 13 times
NEUROENDOCRINE CANCER OF THE PROSTATE METASTATIC is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Microtubule Inhibitor [EPC]
1
0.0000
1
Corticosteroid [EPC]
1
0.0000